2022
DOI: 10.1007/s10238-022-00950-w
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous immunoglobulin therapy in immunoglobulin A vasculitis with gastrointestinal tract involvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…Decreased plasma levels of FXIII have been suggested as a prognostic factor for GI symptoms in IgAV patients, and FXIII replacement therapy has been shown to be effective ( 12 ). Intravenous immunoglobulin (IVIG) and plasmapheresis have also been reported to be effective for GI lesions that are refractory to glucocorticoid therapy ( 13 - 15 ). Several case series of remission induction for glucocorticoid-resistant GI lesions associated with IgAV have been reported ( Table ).…”
Section: Discussionmentioning
confidence: 99%
“…Decreased plasma levels of FXIII have been suggested as a prognostic factor for GI symptoms in IgAV patients, and FXIII replacement therapy has been shown to be effective ( 12 ). Intravenous immunoglobulin (IVIG) and plasmapheresis have also been reported to be effective for GI lesions that are refractory to glucocorticoid therapy ( 13 - 15 ). Several case series of remission induction for glucocorticoid-resistant GI lesions associated with IgAV have been reported ( Table ).…”
Section: Discussionmentioning
confidence: 99%